HEALTH CARE AUTHORITY
[Filed October 24, 2018, 9:46 a.m.]
Preproposal statement of inquiry was filed as WSR 18-13-086.
Title of Rule and Other Identifying Information: WAC 182-553-500 Home infusion therapy and parenteral nutrition program—Coverage, services, limitations, prior authorization, and reimbursement.
Hearing Location(s): On November 27, 2018, at 10:00 a.m., at the Health Care Authority (HCA), Cherry Street Plaza, Pear 107, 626 8th Avenue, Olympia, WA 98504. Metered public parking is available street side around building. A map is available at https://www.hca.wa.gov/assets/program/Driving-parking-checkin-instructions.pdf or directions can be obtained by calling 360-725-1000.
Date of Intended Adoption: Not sooner than November 28, 2018.
Submit Written Comments to: HCA Rules Coordinator, P.O. Box 42716, Olympia, WA 98504-2716, email firstname.lastname@example.org, fax 360-586-9727, by November 27, 2018.
Assistance for Persons with Disabilities: Contact Amber Lougheed, phone 360-725-1349, fax 360-586-9727, telecommunication relay services 711, email email@example.com, by November 23, 2018.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: The agency revised WAC 182-553-500 to:
(1) Allow for coverage of continuous glucose monitoring for adults and pregnant women who meet certain criteria.
(2) Clarify language on home infusion coverage for clients:
(a) Residing in a state-owned facility;
(b) Residing in a nursing facility; or
(c) Electing to receive the agency's hospice benefit.
Reasons Supporting Proposal: See purpose.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: HCA, governmental.
Name of Agency Personnel Responsible for Drafting: Vance Taylor, P.O. Box 42716, Olympia, WA 98504-2716, 360-725-1344; Implementation and Enforcement: Nancy Hite, P.O. Box 42716, Olympia, WA 98504-2716, 360-725-1611.
A school district fiscal impact statement is not required under RCW 28A.305.135
A cost-benefit analysis is not required under RCW 34.05.328
. RCW 34.05.328
does not apply to HCA rules unless requested by the joint administrative rules review committee or applied voluntarily.
The proposed rule does not impose more-than-minor costs on businesses. Following is a summary of the agency's analysis showing how costs were calculated. The revisions to this rule do not impose additional compliance costs or requirements on providers.
October 24, 2018
AMENDATORY SECTION(Amending WSR 15-14-063, filed 6/26/15, effective 7/27/15)
WAC 182-553-500Home infusion therapy and parenteral nutrition program—Coverage, services, limitations, prior authorization, and reimbursement.
(1) The home infusion therapy and parenteral nutrition program covers the following for eligible clients, subject to the limitations and restrictions listed:
(a) A one-month supply of home infusion ((supplies, limited to one month's supply)), per client, per calendar month.
(b) A one-month supply of parenteral nutrition solution((s , limited to one month's supply)), per client, per calendar month.
(c) One type of infusion pump, one type of parenteral pump, and one type of insulin pump per client, per calendar month and as follows:
(i) All rent-to-purchase infusion, parenteral, and insulin pumps must be new equipment at the beginning of the rental period.
(ii) The agency covers the rental payment for each type of infusion, parenteral, or insulin pump for up to twelve months. The agency considers a pump purchased after twelve months of rental payments.
(iii) The agency covers only one purchased infusion pump or parenteral pump per client in a five-year period.
(iv) The agency covers only one purchased insulin pump per client in a four-year period.
(2) Covered supplies and equipment that are within the described limitations listed in subsection (1) of this section do not require prior authorization for reimbursement.
(3) The agency pays for FDA-approved continuous glucose monitoring systems and related monitoring equipment and supplies ((with))using the expedited prior authorization ((for a client who:
(a) Either has had one or more severe episodes of hypoglycemia or is enrolled in a trial approved by an institutional review board;
(b) Is age eighteen and younger;
(c) Has a diagnosis of insulin dependent diabetes mellitus; and
(d) Is followed by an endocrinologist))process when the client meets the following criteria:
(a) Is age eighteen and younger;
(b) Is age nineteen and older with Type 1 diabetes;
(c) Is age nineteen and older with Type 2 diabetes who is:
(i) Unable to achieve target HbA1C despite adherence to an appropriate glycemic management plan after six months of intensive insulin therapy and testing blood glucose four or more times per day;
(ii) Suffering from one or more severe episodes of hypoglycemia despite adherence to an appropriate glycemic management plan; or
(iii) Unable to recognize, or communicate about, symptoms of hypoglycemia.
(d) Is pregnant with:
(i) Type 1 diabetes; or
(ii) Type 2 diabetes and on insulin prior to pregnancy;
(iii) Type 2 diabetes and whose blood glucose does not remain well controlled on diet or oral medication during pregnancy and requires insulin; or
(iv) Gestational diabetes with blood glucose that is not well controlled (HbA1C above target or experiencing episodes of hyperglycemia or hypoglycemia) and requires insulin.
(4) Requests for supplies or equipment that exceed the limitations or restrictions listed in this section require prior authorization and are evaluated on ((an individual basis according to the provisions of))a case-by-case basis under WAC 182-501-0165 and 182-501-0169.
(5) The agency may adopt policies, procedure codes, and rates inconsistent with those set by medicare.
(6) Agency reimbursement for equipment rentals and purchases includes the following:
(a) Instructions to a client, a caregiver, or both, on the safe and proper use of equipment provided;
(b) Full service warranty;
(c) Delivery and pickup; and
(d) Setup, fitting, and adjustments.
(7) ((The agency does not pay separately for home infusion supplies and equipment or parenteral nutrition solutions, except:
(a) When a client resides in a state-owned facility (e.g., state school, a developmental disabilities facility, a mental health facility, Western State Hospital, or Eastern State Hospital).
(b) When a client has elected and is eligible to receive the agency's hospice benefit, unless:
(i) The client has a preexisting diagnosis that requires parenteral support; and
(ii) The preexisting diagnosis is not related to the diagnosis that qualifies the client for hospice.
(8) The agency pays separately for a client's infusion pump, parenteral nutrition pump, insulin pump, solutions, and insulin infusion supplies when the client:
(a) Resides in a nursing facility; and
(b) Meets the criteria in WAC 182-553-300.))For clients residing in a state-owned facility (i.e., state school, developmental disabilities facility, mental health facility, Western State Hospital, and Eastern State Hospital) payment for home infusion supplies, equipment, and parenteral nutrition solutions are the responsibility of the state-owned facility to provide.
(8) For clients who are eligible for and have elected to receive the agency's hospice benefit, the agency pays for home infusion or parenteral nutrition supplies and equipment separately from the hospice per diem rate when:
(a) The client has a preexisting diagnosis that requires parenteral support; and
(b) The preexisting diagnosis is not related to the diagnosis that qualifies the client for hospice.
(9) For clients residing in a nursing facility, infusion pumps, parenteral nutrition pumps, insulin pumps, solutions, and insulin infusion supplies are not included in the nursing facility per diem rate. The agency pays for these items separately.